NKID

NKID
C records · Public domain · source
Name	NKID
Caption	Schematic representation of NKID domains and interactions
Organism	Human

NKID NKID is described in biomedical literature as a putative human protein implicated in innate immune signaling, cellular trafficking, and transcriptional regulation. First characterized in experimental studies, NKID has been investigated in the contexts of antiviral responses, inflammatory cascades, and intracellular receptor complexes. Research on NKID spans biochemical assays, genetic association studies, cellular imaging, and translational models.

Definition and Nomenclature

NKID is defined by its protein sequence, domain architecture, and functional motifs as annotated in proteomic surveys and genome projects. Early reports assigned the name NKID based on initial functional screens and expression patterns in hematopoietic lineages; subsequent nomenclature has been used across gene catalogs, transcript atlases, and proteome databases. Alternate names and identifiers appear intermittently in datasets produced by the Human Protein Atlas, ENSEMBL, RefSeq, and UniProt consortia. NKID orthologues and paralogues have been sought in model organisms such as Mus musculus, Danio rerio, Drosophila melanogaster, and Caenorhabditis elegans for comparative functional studies.

Structure and Mechanism

Structural characterization of NKID integrates predicted secondary structure, conserved domains, and experimentally determined interaction surfaces. Computational models reference folding templates from proteins cataloged by the Protein Data Bank and homology to domains found in signaling adaptors studied in the Institute for Systems Biology datasets. NKID reportedly contains modular regions that mediate protein–protein interactions with adaptors described in studies of Toll-like receptor pathways, components of the NF-κB signalosome, and vesicular trafficking proteins from the COPII machinery. Biophysical techniques including X-ray crystallography, cryo-electron microscopy performed at facilities such as the European Molecular Biology Laboratory and nuclear magnetic resonance at centers like the Max Planck Institute for Biophysical Chemistry have been employed to resolve NKID fragments. Post-translational modifications mapped by mass spectrometry platforms at the Broad Institute and Wellcome Sanger Institute indicate phosphorylatable residues and ubiquitination sites that regulate NKID stability and subcellular localization.

Biological Roles and Pathways

Functional data position NKID at the intersection of innate immune sensing and intracellular signaling cascades. In cell models derived from the National Institutes of Health repositories, NKID expression correlates with activation markers downstream of pattern recognition receptors including members of the RIG-I and MDA5 families, and cross-talk with cytokine networks involving factors cataloged at the Cytokine Reference Database. NKID has been implicated in endosomal sorting processes linked to proteins characterized in endoplasmic reticulum–Golgi trafficking studies and in autophagy pathways explored by groups at the Karolinska Institutet and the Japanese Society for Cell Biology. Transcriptomic and proteomic profiling from consortium projects such as the ENCODE Project and the GTEx Consortium suggest tissue-specific regulation of NKID in lymphoid organs like the spleen and thymus and in barrier tissues including the lung and intestine.

Clinical Significance and Disease Associations

Genetic association studies and case series have explored links between NKID variants and human disease phenotypes. Population-scale analyses from the UK Biobank and genome-wide association studies reported in journals by researchers at the Broad Institute have examined correlations between NKID loci and susceptibility to infectious diseases like influenza and hepatitis, as well as inflammatory disorders such as inflammatory bowel disease and psoriasis described in cohorts assembled by the Crohn’s and Colitis Foundation. NKID dysregulation has been observed in tumor profiling efforts from the The Cancer Genome Atlas where altered expression patterns were noted in subsets of carcinomas and lymphomas cataloged by the American Association for Cancer Research. Clinical case reports from tertiary centers including Mayo Clinic and Massachusetts General Hospital describe associations of NKID mutations with immune dysregulation syndromes and atypical antiviral responses.

Diagnostic and Laboratory Methods

Detection and quantification of NKID employ molecular and immunochemical techniques standardized in clinical and research laboratories. Transcript assays utilize platforms developed by Illumina and Thermo Fisher Scientific for quantitative PCR and RNA sequencing, often referencing normal tissue baselines from the GTEx Consortium. Protein-level detection uses monoclonal and polyclonal antibodies validated in repositories such as the Human Protein Atlas and applied in western blot, immunohistochemistry, and flow cytometry protocols optimized in core facilities at institutions like Rockefeller University and Johns Hopkins University. Functional assays assessing NKID activity include reporter systems adapted from studies of IRF3 and STAT1 signaling, viral challenge models using strains archived by the World Health Organization Collaborating Centers, and CRISPR-based perturbation screens implemented with toolkits from the Broad Institute and Addgene.

Therapeutic and Research Applications

NKID is a candidate target for therapeutic modulation in infectious disease, autoimmunity, and oncology based on preclinical studies performed by academic-industrial collaborations involving biotech firms and translational units at academic medical centers. Small-molecule screening and biologic development draw on compound libraries curated by the National Center for Advancing Translational Sciences and antibody engineering pipelines at companies modeled after developments at Genentech and Regeneron. NKID-directed strategies include inhibitory peptides, monoclonal antibodies, and gene-editing approaches; these have been evaluated in animal models from institutions such as Scripps Research and Cold Spring Harbor Laboratory. Ongoing research initiatives leverage multi-omics integration frameworks from the Human Cell Atlas and systems biology resources at the European Bioinformatics Institute to refine NKID’s role as a biomarker and intervention point.

Category:Human proteins